229 related articles for article (PubMed ID: 17638576)
1. Effects of a monoclonal antibody raised against nerve growth factor on skeletal pain and bone healing after fracture of the C57BL/6J mouse femur.
Koewler NJ; Freeman KT; Buus RJ; Herrera MB; Jimenez-Andrade JM; Ghilardi JR; Peters CM; Sullivan LJ; Kuskowski MA; Lewis JL; Mantyh PW
J Bone Miner Res; 2007 Nov; 22(11):1732-42. PubMed ID: 17638576
[TBL] [Abstract][Full Text] [Related]
2. Nerve growth factor sequestering therapy attenuates non-malignant skeletal pain following fracture.
Jimenez-Andrade JM; Martin CD; Koewler NJ; Freeman KT; Sullivan LJ; Halvorson KG; Barthold CM; Peters CM; Buus RJ; Ghilardi JR; Lewis JL; Kuskowski MA; Mantyh PW
Pain; 2007 Dec; 133(1-3):183-96. PubMed ID: 17693023
[TBL] [Abstract][Full Text] [Related]
3. A blocking antibody to nerve growth factor attenuates skeletal pain induced by prostate tumor cells growing in bone.
Halvorson KG; Kubota K; Sevcik MA; Lindsay TH; Sotillo JE; Ghilardi JR; Rosol TJ; Boustany L; Shelton DL; Mantyh PW
Cancer Res; 2005 Oct; 65(20):9426-35. PubMed ID: 16230406
[TBL] [Abstract][Full Text] [Related]
4. Orthopedic surgery and bone fracture pain are both significantly attenuated by sustained blockade of nerve growth factor.
Majuta LA; Longo G; Fealk MN; McCaffrey G; Mantyh PW
Pain; 2015 Jan; 156(1):157-165. PubMed ID: 25599311
[TBL] [Abstract][Full Text] [Related]
5. Fracture-induced pain-like behaviours in a femoral fracture mouse model.
Magnusdottir R; Gohin S; Ter Heegde F; Hopkinson M; McNally IF; Fisher A; Upton N; Billinton A; Chenu C
Osteoporos Int; 2021 Nov; 32(11):2347-2359. PubMed ID: 34080043
[TBL] [Abstract][Full Text] [Related]
6. Analgesia via blockade of NGF/TrkA signaling does not influence fracture healing in mice.
Rapp AE; Kroner J; Baur S; Schmid F; Walmsley A; Mottl H; Ignatius A
J Orthop Res; 2015 Aug; 33(8):1235-41. PubMed ID: 25876530
[TBL] [Abstract][Full Text] [Related]
7. Anti-nerve growth factor does not change physical activity in normal young or aging mice but does increase activity in mice with skeletal pain.
Majuta LA; Mitchell SAT; Kuskowski MA; Mantyh PW
Pain; 2018 Nov; 159(11):2285-2295. PubMed ID: 29994990
[TBL] [Abstract][Full Text] [Related]
8. Long-term analgesic effect of a single dose of anti-NGF antibody on pain during motion without notable suppression of joint edema and lesion in a rat model of osteoarthritis.
Ishikawa G; Koya Y; Tanaka H; Nagakura Y
Osteoarthritis Cartilage; 2015 Jun; 23(6):925-32. PubMed ID: 25677108
[TBL] [Abstract][Full Text] [Related]
9. Expression of nerve growth factor in the callus during fracture healing in a fracture model in aged mice.
Sekiguchi H; Inoue G; Shoji S; Tazawa R; Kuroda A; Miyagi M; Takaso M; Uchida K
Biomed Mater Eng; 2022; 33(2):131-137. PubMed ID: 34487017
[TBL] [Abstract][Full Text] [Related]
10. Systemic administration of sclerostin monoclonal antibody accelerates fracture healing in the femoral osteotomy model of young rats.
Feng G; Chang-Qing Z; Yi-Min C; Xiao-Lin L
Int Immunopharmacol; 2015 Jan; 24(1):7-13. PubMed ID: 25479724
[TBL] [Abstract][Full Text] [Related]
11. Antibodies to nerve growth factor reverse established tactile allodynia in rodent models of neuropathic pain without tolerance.
Wild KD; Bian D; Zhu D; Davis J; Bannon AW; Zhang TJ; Louis JC
J Pharmacol Exp Ther; 2007 Jul; 322(1):282-7. PubMed ID: 17431136
[TBL] [Abstract][Full Text] [Related]
12. Human parathyroid hormone (1-34) accelerates natural fracture healing process in the femoral osteotomy model of cynomolgus monkeys.
Manabe T; Mori S; Mashiba T; Kaji Y; Iwata K; Komatsubara S; Seki A; Sun YX; Yamamoto T
Bone; 2007 Jun; 40(6):1475-82. PubMed ID: 17369013
[TBL] [Abstract][Full Text] [Related]
13. Comparison of fracture healing among different inbred mouse strains.
Manigrasso MB; O'Connor JP
Calcif Tissue Int; 2008 Jun; 82(6):465-74. PubMed ID: 18528610
[TBL] [Abstract][Full Text] [Related]
14. Targeting nerve growth factor in pain: what is the therapeutic potential?
Watson JJ; Allen SJ; Dawbarn D
BioDrugs; 2008; 22(6):349-59. PubMed ID: 18998753
[TBL] [Abstract][Full Text] [Related]
15. Origins of skeletal pain: sensory and sympathetic innervation of the mouse femur.
Mach DB; Rogers SD; Sabino MC; Luger NM; Schwei MJ; Pomonis JD; Keyser CP; Clohisy DR; Adams DJ; O'Leary P; Mantyh PW
Neuroscience; 2002; 113(1):155-66. PubMed ID: 12123694
[TBL] [Abstract][Full Text] [Related]
16. Preventive or late administration of anti-NGF therapy attenuates tumor-induced nerve sprouting, neuroma formation, and cancer pain.
Jimenez-Andrade JM; Ghilardi JR; Castañeda-Corral G; Kuskowski MA; Mantyh PW
Pain; 2011 Nov; 152(11):2564-2574. PubMed ID: 21907491
[TBL] [Abstract][Full Text] [Related]
17. Preparation and characterization of a high-affinity monoclonal antibody against nerve growth factor.
Liu S; Shen Y; Chen P; Guo C; Zhang G; Jiang X; He J; Yang J
Protein Expr Purif; 2022 Jan; 189():105966. PubMed ID: 34627999
[TBL] [Abstract][Full Text] [Related]
18. C5aR inhibition in the early inflammatory phase does not affect bone regeneration in a model of uneventful fracture healing.
Ehrnthaller C; Huber-Lang M; Kovtun A; Rapp AE; Kemmler J; Gebhard F; Ignatius A
Eur J Med Res; 2016 Oct; 21(1):42. PubMed ID: 27784330
[TBL] [Abstract][Full Text] [Related]
19. Anti-nerve growth factor therapy increases spontaneous day/night activity in mice with orthopedic surgery-induced pain.
Majuta LA; Guedon JG; Mitchell SAT; Ossipov MH; Mantyh PW
Pain; 2017 Apr; 158(4):605-617. PubMed ID: 28301858
[TBL] [Abstract][Full Text] [Related]
20. Anti-NGF therapy profoundly reduces bone cancer pain and the accompanying increase in markers of peripheral and central sensitization.
Sevcik MA; Ghilardi JR; Peters CM; Lindsay TH; Halvorson KG; Jonas BM; Kubota K; Kuskowski MA; Boustany L; Shelton DL; Mantyh PW
Pain; 2005 May; 115(1-2):128-41. PubMed ID: 15836976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
